Katleen Vandersmissen is Head of Health & Care and member of the management committee at LRM, an investment company which develops and fosters economic growth in Limburg (Belgium). She is a board member of several portfolio companies such as EpiGaN, Apitope, New Vision and Bedal. Before joining LRM in 2013, she worked as a consultant for McKinsey & Co. and held positions at Umicore in R&D and Investor Relations.
She graduated summa cum laude from the University of Leuven in Chemistry and obtained a PhD in science from the same university. Later she obtained a degree in Corporate Finance from the University of Leuven and a post graduate in Corporate Law from HUB-EHSAL.
Get in touch: